$ELDN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eledon Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Eledon Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eledon Pharmaceuticals, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 5,919 | 84,050 | 4,561,393 | 4.6 M to 4.6 M (-0.13 %) |
| Jun 12 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.20 | 27,875 | 395,825 | 4,567,312 | 4.6 M to 4.6 M (-0.61 %) |
| May 28 2015 | TKAI | Tokai Pharmaceutic ... | Quirk Gerald E | General Counsel, Ex ... | Option Exercise | A | 10.81 | 214,605 | 2,319,880 | 214,605 | |
| Apr 20 2015 | TKAI | Tokai Pharmaceutic ... | Kalowski Lee | Chief Financial Off ... | Sell | S | 13.00 | 4,567 | 59,371 | 47,779 | 52.3 K to 47.8 K (-8.72 %) |
| Apr 13 2015 | TKAI | Tokai Pharmaceutic ... | Cohen Cheryl | Director | Option Exercise | A | 11.08 | 25,000 | 277,000 | 25,000 | |
| Apr 06 2015 | TKAI | Tokai Pharmaceutic ... | Kalowski Lee | Chief Financial Off ... | Sell | S | 11.45 | 2,258 | 25,854 | 52,346 | 54.6 K to 52.3 K (-4.14 %) |
| Mar 20 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.50 | 46,141 | 669,045 | 4,595,187 | 4.6 M to 4.6 M (-0.99 %) |
| Mar 20 2015 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 14.50 | 3,000 | 43,500 | 4,641,328 | 4.6 M to 4.6 M (-0.06 %) |
| Jan 12 2015 | TKAI | Tokai Pharmaceutic ... | Buckley Stephen Jr. | Director | Option Exercise | A | 14.49 | 25,000 | 362,250 | 25,000 | |
| Oct 17 2014 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | A | 13.25 | 134,134 | 1,777,276 | 134,134 | |
| Oct 17 2014 | TKAI | Tokai Pharmaceutic ... | McBride John S. | Chief Operating Off ... | Option Exercise | A | 13.25 | 50,671 | 671,391 | 50,671 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 8,013,003 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 3,931,085 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 457,728 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 4,577,315 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Satter Muneer A | 10% Owner | Buy | P | 15.00 | 150,000 | 2,250,000 | 1,771,688 | 1.6 M to 1.8 M (+9.25 %) |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Satter Muneer A | 10% Owner | Buy | C | 0.00 | 1,621,688 | 0 | 1,621,688 | 0 to 1.6 M |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Apple Tree Partners II - Annex ... | Director | Option Exercise | C | 0.00 | 24,199,308 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Apple Tree Partners II - Annex ... | Director | Option Exercise | C | 0.00 | 10,675,613 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Apple Tree Partners II - Annex ... | Director | Buy | P | 15.00 | 237,500 | 3,562,500 | 3,568,438 | 3.3 M to 3.6 M (+7.13 %) |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Apple Tree Partners II - Annex ... | Director | Buy | C | 0.00 | 3,330,938 | 0 | 3,330,938 | 0 to 3.3 M |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 13,370,422 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 1,539,643 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 8,711,335 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 14,604,833 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 644,786 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 798,067 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Option Exercise | C | 0.00 | 4,500,000 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | APPLE TREE PARTNERS II LP | Director | Buy | C | 0.00 | 4,218,632 | 0 | 4,218,641 | 9 to 4.2 M (+46,873,688.89 %) |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 24,199,308 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 24,046,035 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 1,539,643 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 8,711,335 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 14,604,833 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 644,786 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 798,067 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Option Exercise | C | 0.00 | 4,500,000 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Buy | P | 15.00 | 362,500 | 5,437,500 | 7,912,079 | 7.5 M to 7.9 M (+4.80 %) |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Harrison Seth Loring | Director | Buy | C | 0.00 | 7,549,570 | 0 | 7,549,579 | 9 to 7.5 M (+83,884,111.11 %) |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | BARBERICH TIMOTHY J | Director | Option Exercise | C | 0.00 | 809,955 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | BARBERICH TIMOTHY J | Director | Option Exercise | C | 0.00 | 457,731 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | BARBERICH TIMOTHY J | Director | Buy | C | 0.00 | 121,077 | 0 | 121,077 | 0 to 121.1 K |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 15,064,469 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 13,222,826 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 1,539,643 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Option Exercise | C | 0.00 | 15,396,431 | 0 | 0 | |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | P | 15.00 | 325,000 | 4,875,000 | 4,644,328 | 4.3 M to 4.6 M (+7.52 %) |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Novartis Bioventures Ltd | 10% Owner | Buy | C | 0.00 | 4,319,328 | 0 | 4,319,328 | 0 to 4.3 M |
| Sep 24 2014 | TKAI | Tokai Pharmaceutic ... | Morrison Jodie Pope | President and CEO | Option Exercise | A | 1.58 | 165,251 | 261,097 | 165,251 | |
| Sep 18 2014 | TKAI | Tokai Pharmaceutic ... | Kalowski Lee | Chief Financial Off ... | Option Exercise | A | 15.00 | 218,417 | 3,276,255 | 218,417 | |
| Sep 18 2014 | TKAI | Tokai Pharmaceutic ... | Kalowski Lee | Chief Financial Off ... | Grant | A | 0.00 | 54,604 | 0 | 54,604 | 0 to 54.6 K |